Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96,015,846
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
17,375,298
-
Shares change
-
+1,622,458
-
Total reported value, excl. options
-
$211,265,514
-
Value change
-
+$20,553,121
-
Put/Call ratio
-
26.71%
-
Number of buys
-
29
-
Number of sells
-
-26
-
Price
-
$12.16
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q3 2021
75 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q3 2021.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,375,298 shares
of 96,015,846 outstanding shares and own 18.1% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (3,041,645 shares), 5AM Venture Management, LLC (2,359,263 shares), Cormorant Asset Management, LP (1,611,623 shares), BOXER CAPITAL, LLC (1,603,361 shares), Ikarian Capital, LLC (1,187,898 shares), Point72 Asset Management, L.P. (900,000 shares), VANGUARD GROUP INC (730,781 shares), Redmile Group, LLC (696,377 shares), BAKER BROS. ADVISORS LP (662,063 shares), and CITADEL ADVISORS LLC (559,467 shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.